Suchergebnisse - "Merchant, Rosemina"

PubPharm (18)

1

IL-4R AS A BIOMARKER IN CANCER

enthalten in: Europäisches Patentamt | 2022

von MERCHANT FAHAR | MERCHANT ROSEMINA

2

Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate

enthalten in: Journal for immunotherapy of cancer | 2022

von Merchant, R. | Galligan, C. | Munegowda, M. | +5

3

IL-4R AS A BIOMARKER IN CANCER

enthalten in: Europäisches Patentamt | 2021

von MERCHANT FAHAR | MERCHANT ROSEMINA

4

IL-4R AS A BIOMARKER IN CANCER

enthalten in: Europäisches Patentamt | 2021

von MERCHANT FAHAR | MERCHANT ROSEMINA

5

IL-4R AS A BIOMARKER IN CANCER

enthalten in: Europäisches Patentamt | 2020

von MERCHANT FAHAR | MERCHANT ROSEMINA

6

IL-4R AS A BIOMARKER IN CANCER

enthalten in: Europäisches Patentamt | 2020

von MERCHANT FAHAR | MERCHANT ROSEMINA

7

A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic Disease

enthalten in: Journal of the National Cancer Institute | 2013

von Williams, S. | Merchant, R. | Garrett-Mayer, E. | +3

8

Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia

enthalten in: The Journal of urology | 2013

von Elhilali, M. | Pommerville, P. | Yocum, R. | +3

CommentIn: Nat Rev Urol. 2013 Jan;10(1):3. - PMID 23183948

9

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

enthalten in: The journal of urology | 2013

von Elhilali, M. | Pommerville, P. | Yocum, R. | +3

10

Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

enthalten in: European urology | 2011

von Denmeade, S. | Egerdie, B. | Steinhoff, G. | +3

CommentIn: Eur Urol. 2011 May;59(5):755-6. - PMID 21330048